AIkido Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $14,346,000.

Profit Margin

AIkido Pharma Inc. (NASDAQ:AIKI): Profit margin
2013 27K -17.96M -66537.04%
2014 10K -30.53M -305320%
2015 33K -51.46M -155954.55%
2016 877K -6.47M -738.43%
2017 1.23M -3.30M -267.48%
2018 28K 1.72M 6167.86%
2019 9K -4.18M -46477.78%
2020 0 -12.33M
2021 0 -4.90M
2022 0 -29.86M

AIKI Income Statement (2013 โ€“ 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
0009K28K1.23M877K33K10K27K
Cost of revenue
000081K92K84K88K864K3K
Gross profit
0009K-53K1.14M793K-55K-854K24K
Operating exp.
Research and development
830K559K2.48M2.52M0000010K
Selling and marketing
0000000000
Total operating expenses
14.34M9.44M6.54M5.69M4.49M5.05M6.71M11.44M30.62M15.37M
Operating income
-14.34M-9.44M-6.54M-5.68M-6.87M-3.82M-8.55M-52.01M-30.61M-15.34M
Other income (expenses), net
-7.76M2.27M-5.79M1.50M8.60M516K2.07M545K79K-2.61M
Income before tax
-22.10M-7.17M-12.33M-4.18M1.72M-3.30M-6.47M-51.46M-30.53M-17.96M
Income tax expense
7.76M-2.27M008.60M516K2.07M545K79K-2.61M
Net income
-29.86M-4.90M-12.33M-4.18M1.72M-3.30M-6.47M-51.46M-30.53M-17.96M
Earnings per share
Basic EPS
-5.6-2.97-7.47-28.3115.48-43.13-126.45-2.19K-2.12K-18.73K
Diluted EPS
-5.6-2.97-7.47-28.3115.48-43.13-121.9-2.19K-2.12K-18.73K
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source